KLRS
Price:
$5.92
Market Cap:
$110.72M
Kalaris Therapeutics Inc operates as a pharmaceutical company. The Company specializes in the development of novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems.
Industry
Biotechnology
IPO Date
2020-07-30
Stock Exchange
NASDAQ
Ticker
KLRS
According to Kalaris Therapeutics Inc’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.
The mean historical Dividend Yield of Kalaris Therapeutics Inc over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), KLRS's Dividend Yield was at its highest in in the March 2019 quarter at 0%. The Dividend Yield was at its lowest in in the March 2019 quarter at 0%.
Average
0%
Median
0%
Minimum
0%
Maximum
0%
Discovering the peaks and valleys of Kalaris Therapeutics Inc Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Dividend Yield = 0%
Minimum Annual Increase = 0%
Minimum Annual Dividend Yield = 0%
| Year | Dividend Yield | Change |
|---|---|---|
| 2024 | 0% | 0% |
| 2023 | 0% | 0% |
| 2022 | 0% | 0% |
| 2021 | 0% | 0% |
| 2020 | 0% | 0% |
| 2019 | 0% | 0% |
The current Dividend Yield of Kalaris Therapeutics Inc (KLRS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0%
5-year avg
0%
10-year avg
0%
Kalaris Therapeutics Inc’s Dividend Yield is less than InflaRx N.V. (0%), less than ImageneBio Inc (0%), less than Connect Biopharma Holdings Limited (0%), less than Shattuck Labs, Inc. (0%), less than Sutro Biopharma, Inc. (0%), less than Artiva Biotherapeutics, Inc. (0%), less than Metagenomi, Inc. Common Stock (0%), less than Context Therapeutics Inc. (0%), less than Quince Therapeutics, Inc. (0%), less than Ovid Therapeutics Inc. (0%),
| Company | Dividend Yield | Market cap |
|---|---|---|
| 0% | $74.52M | |
| 0% | $75.81M | |
| 0% | $141.98M | |
| 0% | $142.27M | |
| 0% | $79.86M | |
| 0% | $92.66M | |
| 0% | $67.21M | |
| 0% | $94.64M | |
| 0% | $200.45M | |
| 0% | $115.21M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kalaris Therapeutics Inc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Kalaris Therapeutics Inc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Dividend Yield?
How can you use the Dividend Yield?
What is Kalaris Therapeutics Inc's Dividend Yield?
How is the Dividend Yield calculated for Kalaris Therapeutics Inc (KLRS)?
What is the highest Dividend Yield for Kalaris Therapeutics Inc (KLRS)?
What is the 3-year average Dividend Yield for Kalaris Therapeutics Inc (KLRS)?
What is the 5-year average Dividend Yield for Kalaris Therapeutics Inc (KLRS)?
How does the current Dividend Yield for Kalaris Therapeutics Inc (KLRS) compare to its historical average?